(E/Z)-AG490 |
| Catalog No.GC61807 |
(E/Z)-AG490((E/Z)-Tyrphostin AG490)은 (E)-AG490 및 (Z)-AG490 이성질체의 라세미 화합물입니다. (E)-AG490은 EGFR, Stat-3 및 JAK2/3을 억제하는 티로신 키나제 억제제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 134036-52-5
Sample solution is provided at 25 µL, 10mM.
Product has been cited by 1 publications
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
(E/Z)-AG490 ((E/Z)-Tyrphostin AG490) is a racemic compound of (E)-AG490 and (Z)-AG490 isomers. (E)-AG490 is a tyrosine kinase inhibitor that inhibits EGFR, Stat-3 and JAK2/3.
| Cas No. | 134036-52-5 | SDF | |
| Canonical SMILES | O=C(NCC1=CC=CC=C1)/C(C#N)=C/C2=CC=C(O)C(O)=C2 | ||
| Formula | C17H14N2O3 | M.Wt | 294.3 |
| Solubility | Storage | Store at -20°C | |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.3979 mL | 16.9895 mL | 33.9789 mL |
| 5 mM | 0.6796 mL | 3.3979 mL | 6.7958 mL |
| 10 mM | 0.3398 mL | 1.6989 mL | 3.3979 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC31911 CCR2 antagonist 3
- GN10335 Mesaconitine
- GC33687 Glycoursodeoxycholic acid (Ursodeoxycholylglycine)
- GC43937 JWH 018 4-hydroxyindole metabolite
- GC10695 Neuropeptide Y (scrambled)
- GC44047 LDN-192960 (hydrochloride)
- GC42660 A-39183A
- GC39153 PGLa TFA
- GN10256 Protodioscin
- GC60628 BD750
- GC31313 S16961 (S169611)
- GC11426 BAY 41-8543
- GC17866 INCB28060
- GC31496 DO34 analog
- GC19137 EMA401
- GC35639 CEF1, Influenza Matrix Protein M1 58-66
- GC45434 Dipeptide diaminobutyroyl benzylamide (acetate)
리뷰
Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *